Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Tumour Lysis Syndrome

idarubicin has been researched along with Tumour Lysis Syndrome in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brierley, CK; Eyre, TA1
Fujii, S; Kikuchi, T; Miyata, A1

Other Studies

2 other study(ies) available for idarubicin and Tumour Lysis Syndrome

ArticleYear
Acute monoblastic leukemia presenting with striking periorbital and periauricular infiltration.
    Blood, 2017, 06-22, Volume: 129, Issue:25

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Ear, External; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hearing Loss, Unilateral; Humans; Idarubicin; Leukemia, Monocytic, Acute; Leukemic Infiltration; Male; Orbit; Tumor Lysis Syndrome; Vidarabine

2017
[Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Tumor Lysis Syndrome

2003